Peer Review History
| Original SubmissionAugust 17, 2022 |
|---|
|
PONE-D-22-20511Exploring diabetes status and social determinants of health influencing diabetes-related complications in a Northwestern Ontario - A mixed method study protocolPLOS ONE Dear Dr. Costa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Authors are suggested to strengthen their literature review of the topic, add strong rationale to the study, and justify the need to do mixed methods and the choice of parallel mixed methods design compared to others. Specific reviewers' comments are given below. Please submit your revised manuscript by 23rd February 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sana Sadiq Sheikh Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. Additional Editor Comments (if provided): Please find the reviewers' comments below. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. Please use same unique referencing format in whole the paper. For example, in the Introduction, line 5 you are suing two different formats. Same in the second page of Introduction, second paragraph line 7. 2. Please justify why you are doing both quantitative and qualitative studies parallel? 3. For the quantitative study, please explain what are the exclusion criteria? 4. For the qualitative study, what are the exclusion criteria? 5. For the qualitative study, please explain what you will do to increase trustworthiness such as credibility, transferability,…(study rigor). 6. Who will conduct the interviews? Reviewer #2: It was a pleasure to review and learn about your work which I believe is very relevant to the research community as well as population health. While I found this a fair read, I have the following comments and considerations to work on and address. General comments Pay attention to claims without appropriate interpretation of reference Provide reference citations for assertions that are not yours A few grammatical and syntactical errors are replete in your piece. Address them Ensure references are in alignment with PONE author guidelines (including dois where necessary, date of access for URLs, etc) Specific comments More context on the burden of DM on the local community in NWO compared to neighbouring areas would be necessary to understand and justify the research inquiry “While, the focus of most studies has been on pharmacological and technical approaches to manage diabetes,” cite the studies that focus on pharmacological techniques. I beg to disagree because a cursory online scan of studies on DM in NWO shows a few studies focusing on DM epidemiology and outcomes. “To date, no published study has explored the impact of gender, race/ethnicity and social determinants of health on diabetes-related complications for individuals living in Northwestern Ontario”. As commented above, I disagree. Consider rephrasing as it is not totally true. There are a few studies albeit, localized or published over a decade. Often lazy scholars use the idea of ‘no evidence’ to rationalize study objectives when they failed to do a proper review of literature “Northwestern Ontario (NOW)” do you mean NWO here. “However, there is evidence that Canadian population with diabetes who are living in remote and rural areas of Northwestern Ontario are facing lots of challenges in addressing social and economic determinants of health, particularly food insecurity and access to services and resources to support their diabetes management” Provide the evidence by citing the source! “Population groups that have more difficulty to access, services, resources, and fresh and healthy food due to financial constraints and low-income households, include those with lower levels of education, Indigenous peoples, and those living in remote regions [14]. Therefore, nonpharmacological interventions that addresses the social determinants of health and enhance selfcare behaviours may lead to prevention of diabetes-related complications improve quality of life and decrease the economic burden of disease [15], especially for people with Type 2 diabetes in rural and remote areas of Northwestern Ontario.” This is a valid point but the delivery could be re-structured to show the linkages between socio-personal determinants of health and food insecurity which I think is the point you trying to drive home here. “However, the relationships between social economic factor and individuals’ attributes are not totally clear” what does literature say about this that is not totally clear? Include it, analysing for the gaps in literature and how your proposal will help bridge that gap. Don’t just provide vague and generic statements. “Thus, in response to this gap, this research study will firstly use a cross-sectional design to identify the prevalence of diabetes complications, the internal and external factors affecting diabetes’ outcomes in a Northwestern Community. Secondly, it will employ a critical pedagogy approach to explore the needs, motivations and struggles individuals with diabetes face to selfmanage the disease on a daily basis.” This should be for the methods section. Move it. Methods “parallel mixed-method approach” it will be a good place to explain parallel mixed-method approach and why it best fits to answer your research questions. The region of NOW has a significant amount of Indigenous communities of whom have higher inequalities socially, and clinically. I didn’t see how your proposal is designed to address Indigenous health from a community-led/engaged perspective. Indigenous peoples have higher rates of DM than non-Indigenous peoples. What engagement strategies, protocols and pursuits are in place to address inequalities in for this group of people? I need more information on how the findings from this study would benefit patients with DM with regard to self-care, self-reliance, health promotion, and rehospitalization. Your focus is more on policy and population health but less on the individual scale. Have included how your study will not add to increase health inequalities in other areas of chronic disease care and will address equity, diversity and inclusion of participants. Comment on knowledge translation considerations as well. How will data findings be made available to relevant stakeholders ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Masoud Mohammadnezhad Reviewer #2: Yes: Udoka Okpalauwaekwe ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-20511R1Exploring diabetes status and social determinants of health influencing diabetes-related complications in a Northwestern Community, Ontario, Canada: A mixed method study protocolPLOS ONE Dear Dr. Costa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see the comments from the reviewers. Make necessary edits and send us back the revised manuscripts with changes. Please submit your revised manuscript by 30 days. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, AKM Alamgir, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for considering all my comments. All the changes are made and the quality has promoted well. Reviewer #2: Thank you for the opportunity to review your work again. While I commend your efforts to improve on the quality per reviewer comments, I have a few comments for considerations. Confirm the following in your methods Will data for the quantitative arm be collected `prospectively or retrospectively? Would patient participants provide consent for their data to be collected via their charts? Will participants be recruited first before data collection. Your order of proceedings makes it seem like they wouldn’t. For the qualitative part Who developed the interview guide? Were patients involved in the co-development (if that was done). Any field test of the guide for language, comprehension, etc? Your KT planes seem rather vague here “We also plan to disseminate the research findings to participants, healthcare professionals, and knowledge users beyond the research community by using a non-academic mode of communication such as face-to-face meetings, workshop settings, and social media such as blogs, podcasting, and webinars. In this strategy our goal is to adapt the language of the publication to the target audiences by using plain language to help them understand the research findings at their level.” Who has been engaged so far with this work you are doing? How would you engage them to use the findings. The aim of KT is beyond publication, but engagement to knowledge use and implementation. I would be interested to see what has been done with this piece so far and not what you plan to do in the future. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Masoud Mohammadnezhad Reviewer #2: Yes: Udoka Okpalauwaekwe ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Exploring diabetes status and social determinants of health influencing diabetes-related complications in a Northwestern Ontario - A mixed method study protocol PONE-D-22-20511R2 Dear Dr. Idevania Costa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, AKM Alamgir, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: It was a pleasure reviewing your work again. Thanks for paying attention to the comments preferred. Wish you the best. Sincerely Reviewer #3: When we are considering the local population of northwestern Canada, why was an interpreter not made available? As I understand The native language is not English, to understand the practices for managing diabetes by the local population study should have included the non-English local population with the availability of an interpreter. This would help us to get more diabetics patients for our study. Reviewer #4: Thank you very much for the opportunity to review your manuscript. The proposal appears sound, and thorough. 1. For demographic data collection - it might be beneficial to also collect data on racial/ ethnic background - specifically native/ immigrant backgrounds It would be helpful to have a little bit more detail about social constructivist approach. Why is it better than other approaches. I understand that it may allow us to better explore the social lived experience of having diabetes, and how that impacts on their health, but more detail might be beneficial. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Udoka Okpalauwaekwe Reviewer #3: Yes: Nishat Mehdi Reviewer #4: No ********** |
| Formally Accepted |
|
PONE-D-22-20511R2 Exploring diabetes status and social determinants of health influencing diabetes-related complications in a Northwestern Community, Ontario, Canada: A mixed method study protocol Dear Dr. Costa: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr AKM Alamgir Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .